DIARRHOEA is the #4 most commonly reported adverse reaction for GLIPIZIDE, manufactured by Roerig. There are 3,262 FDA adverse event reports linking GLIPIZIDE to DIARRHOEA. This represents approximately 2.8% of all 115,301 adverse event reports for this drug.
Patients taking GLIPIZIDE who experience diarrhoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DIARRHOEA3,262 of 115,301 reports
DIARRHOEA is a less commonly reported adverse event for GLIPIZIDE, but still significant enough to appear in the safety profile.
Other Side Effects of GLIPIZIDE
In addition to diarrhoea, the following adverse reactions have been reported for GLIPIZIDE:
DIARRHOEA has been reported as an adverse event in 3,262 FDA reports for GLIPIZIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DIARRHOEA with GLIPIZIDE?
DIARRHOEA accounts for approximately 2.8% of all adverse event reports for GLIPIZIDE, making it a notable side effect.
What should I do if I experience DIARRHOEA while taking GLIPIZIDE?
If you experience diarrhoea while taking GLIPIZIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.